192 related articles for article (PubMed ID: 32140372)
1. Infection-related Glomerulonephritis and C3 Glomerulonephritis - Similar Yet Dissimilar: A Case Report and Brief Review of Current Literature.
Chamarthi G; Clapp WL; Bejjanki H; Auerbach J; Koratala A
Cureus; 2020 Feb; 12(2):e7127. PubMed ID: 32140372
[TBL] [Abstract][Full Text] [Related]
2. Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience.
Viswanathan GK; Nada R; Kumar A; Ramachandran R; Rayat CS; Jha V; Sakhuja V; Joshi K
Diagn Pathol; 2015 Mar; 10():6. PubMed ID: 25889427
[TBL] [Abstract][Full Text] [Related]
3. Clinico-Pathogenic Similarities and Differences between Infection-Related Glomerulonephritis and C3 Glomerulopathy.
Wada Y; Kamata M; Miyasaka R; Abe T; Kawamura S; Takeuchi K; Aoyama T; Oda T; Takeuchi Y
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176142
[TBL] [Abstract][Full Text] [Related]
4. Morphological and etiological analyses of C3 and non-C3 glomerulonephritis in primary membranoproliferative glomerulonephritis using periodic acid-methenamine silver stain electron microscopy: a retrospective multicentered study.
Honma S; Sato N; Sakaguchi R; Hashiguchi A; Uesugi N; Nakamura Y; Sasano H; Joh K
Med Mol Morphol; 2024 Mar; 57(1):23-34. PubMed ID: 37823929
[TBL] [Abstract][Full Text] [Related]
5. Endocarditis-Associated C3-Dominant Glomerulonephritis in a Patient With a Solitary Kidney.
Chowdhury L; Alobaidi A; Lytvak I
Cureus; 2022 Aug; 14(8):e27675. PubMed ID: 35935112
[TBL] [Abstract][Full Text] [Related]
6. Glomerular paramesangial deposits: association with hypocomplementemia in membranoproliferative glomerulonephritis types I and III.
West CD; McAdams AJ
Am J Kidney Dis; 1998 Mar; 31(3):427-34. PubMed ID: 9506679
[TBL] [Abstract][Full Text] [Related]
7. Severe active C3 glomerulonephritis triggered by immune complexes and inactivated after eculizumab therapy.
Kersnik Levart T; Ferluga D; Vizjak A; Mraz J; Kojc N
Diagn Pathol; 2016 Oct; 11(1):94. PubMed ID: 27717365
[TBL] [Abstract][Full Text] [Related]
8. Asymptomatic sinusitis as an origin of infection-related glomerulonephritis manifesting steroid-resistant nephrotic syndrome: A case report.
Noda S; Mandai S; Oda T; Shinoto T; Sato H; Sato K; Hirokawa K; Noda Y; Uchida S
Medicine (Baltimore); 2020 Jun; 99(25):e20572. PubMed ID: 32569182
[TBL] [Abstract][Full Text] [Related]
9. Membranoproliferative glomerulonephritis and C3 glomerulonephritis: frequency, clinical features, and outcome in children.
Okuda Y; Ishikura K; Hamada R; Harada R; Sakai T; Hamasaki Y; Hataya H; Fukuzawa R; Ogata K; Honda M
Nephrology (Carlton); 2015 Apr; 20(4):286-92. PubMed ID: 25524631
[TBL] [Abstract][Full Text] [Related]
10. Demographic, clinical characteristics and treatment outcomes of immune-complex membranoproliferative glomerulonephritis and C3 glomerulonephritis in Japan: A retrospective analysis of data from the Japan Renal Biopsy Registry.
Nakagawa N; Mizuno M; Kato S; Maruyama S; Sato H; Nakaya I; Sugiyama H; Fujimoto S; Miura K; Matsumura C; Gotoh Y; Suzuki H; Kuroki A; Yoshino A; Nakatani S; Hiromura K; Yamamoto R; Yokoyama H; Narita I; Isaka Y
PLoS One; 2021; 16(9):e0257397. PubMed ID: 34520493
[TBL] [Abstract][Full Text] [Related]
11. Dense intramembranous deposit disease: new pathologic features.
Sibley RK; Kim Y
Kidney Int; 1984 Apr; 25(4):660-70. PubMed ID: 6482170
[TBL] [Abstract][Full Text] [Related]
12. Pathological implications of linear immunoglobulin G staining on the glomerular capillary walls in a case of infection-related glomerulonephritis.
Fujigaki Y; Kawamorita Y; Yamaguchi H; Arai S; Tamura Y; Ota T; Shibata S; Kondo F; Yamaguchi Y; Uchida S
Pathol Int; 2016 Sep; 66(9):524-8. PubMed ID: 27465582
[TBL] [Abstract][Full Text] [Related]
13. A Case of Switch from C3 Glomerulonephritis to Proliferative Glomerulonephritis with Monoclonal IgG Deposits.
Zhang F; Gao E; Liang S; Yang N; Wang J
Ann Clin Lab Sci; 2018 Jul; 48(4):528-533. PubMed ID: 30143498
[TBL] [Abstract][Full Text] [Related]
14. Nephritis-associated plasmin receptor (NAPlr) positive glomerulonephritis caused by Aggregatibacter actinomycetemcomitans bacteremia: A case report.
Komaru Y; Ishioka K; Oda T; Ohtake T; Kobayashi S
Clin Nephrol; 2018 Aug; 90(2):155-160. PubMed ID: 29578396
[TBL] [Abstract][Full Text] [Related]
15. The features in IgA-dominant infection-related glomerulonephritis distinct from IgA nephropathy: a single-center study.
Handa T; Kakita H; Tateishi Y; Endo T; Suzuki H; Katayama T; Tsukamoto T; Muso E
Clin Exp Nephrol; 2018 Oct; 22(5):1116-1127. PubMed ID: 29564665
[TBL] [Abstract][Full Text] [Related]
16. C4d as a Diagnostic Tool in Proliferative GN.
Sethi S; Nasr SH; De Vriese AS; Fervenza FC
J Am Soc Nephrol; 2015 Nov; 26(11):2852-9. PubMed ID: 25991041
[TBL] [Abstract][Full Text] [Related]
17. C3 glomerulonephritis with a severe crescentic phenotype.
Ravindran A; Fervenza FC; Smith RJH; Sethi S
Pediatr Nephrol; 2017 Sep; 32(9):1625-1633. PubMed ID: 28593446
[TBL] [Abstract][Full Text] [Related]
18. [Crescentic and necrotizing glomerulonephritis with C3 deposition].
Tsukada Y; Wakabayashi Y; Suetsugu Y; Hamaguchi K; Fukui A; Ogura M; Hosoya T
Nihon Jinzo Gakkai Shi; 2008; 50(1):51-8. PubMed ID: 18318244
[TBL] [Abstract][Full Text] [Related]
19. Differences in clinical findings, pathology, and outcomes between C3 glomerulonephritis and membranoproliferative glomerulonephritis.
Kawasaki Y; Kanno S; Ono A; Suzuki Y; Ohara S; Sato M; Suyama K; Hashimoto K; Hosoya M
Pediatr Nephrol; 2016 Jul; 31(7):1091-9. PubMed ID: 26846787
[TBL] [Abstract][Full Text] [Related]
20. A case of C3 glomerulonephritis successfully treated with eculizumab.
Payette A; Patey N; Dragon-Durey MA; Frémeaux-Bacchi V; Le Deist F; Lapeyraque AL
Pediatr Nephrol; 2015 Jun; 30(6):1033-7. PubMed ID: 25796589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
